BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 11543987)

  • 1. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
    Schütz CG; Rapiti E; Vlahov D; Anthony JC
    Drug Alcohol Depend; 1994 Oct; 36(2):129-38. PubMed ID: 7851280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients.
    Backmund M; Meyer K; Henkel C; Soyka M; Reimer J; Schütz CG
    J Addict Dis; 2005; 24(4):17-29. PubMed ID: 16368654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728].
    Oldham NS; Wright NM; Adams CE; Sheard L; Tompkins CN
    BMC Fam Pract; 2004 Apr; 5():9. PubMed ID: 15117415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
    Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
    Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A path analysis of cognitive, affective, and behavioral predictors of treatment response in a methadone maintenance program.
    Avants SK; Margolin A; Mckee S
    J Subst Abuse; 2000; 11(3):215-30. PubMed ID: 11026121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 9. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions.
    Metrebian N; Shanahan W; Wells B; Stimson GV
    Med J Aust; 1998 Jun; 168(12):596-600. PubMed ID: 9673620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone maintenance and recovery from opioid dependence.
    Maddux JF; Desmond DP
    Am J Drug Alcohol Abuse; 1992; 18(1):63-74. PubMed ID: 1562007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol consumption in heroin users, methadone-substituted and codeine-substituted patients--frequency and correlates of use.
    Backmund M; Schütz CG; Meyer K; Eichenlaub D; Soyka M
    Eur Addict Res; 2003 Jan; 9(1):45-50. PubMed ID: 12566797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of injecting and injecting risk-taking behaviour among methadone-maintenance clients.
    Darke S; Swift W; Hall W; Ross M
    Addiction; 1994 Mar; 89(3):311-6. PubMed ID: 8173500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-frequency users of detoxification: who are they?
    Amodeo M; Lundgren L; Chassler D; Witas J
    Subst Use Misuse; 2008; 43(7):839-49. PubMed ID: 18570019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over- and underreporting of recent drug use in subjects entering an inpatient detoxification unit.
    Zullino DF; Krenz S; Eap CB; Benguettat D; Khan R
    Eur J Med Res; 2008 Jan; 13(1):15-20. PubMed ID: 18226992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple predictors of illicit drug use in methadone maintenance clients.
    Gollnisch G
    Addict Behav; 1997; 22(3):353-66. PubMed ID: 9183505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.